BioCentury
ARTICLE | Clinical News

Edarbyclor azilsartan medoxomil/chlorthalidone regulatory update

October 8, 2012 7:00 AM UTC

Takeda said that within the first 8 months of this year, it submitted regulatory applications for azilsartan medoxomil/chlorthalidone in Taiwan, Thailand and Indonesia to treat hypertension. Takeda ma...